SuperworthTenon Medical TNON
- Market cap
- $1.5M
- PE
- n/m
- a loss over the last year
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- 0.3×
- EV/EBIT
- n/m
- a loss over the last year
- Revenue, 12 months
- $5.3M
- +80% on a year ago
- Net margin
- n/m
- outside −100% to 100%
- Free cash flow yield
- −822.8%
Tenon Medical trades at 0.3× sales. Its trailing earnings are negative, so it has no PE. Revenue was $5.3M over the last twelve months, up 80% on a year earlier.
Charts
Financials
| Income statement | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $944K+354% | $808K+192% | $719K+66% | $901K+21% | $887K−6% | $770K−5% | $726K+1% | $564K−37% | $1.2M+32% | $1.5M+92% | $1.4M+90% | $1.3M+127% | |
| Cost of revenue | $409K+35% | $249K−49% | $249K−48% | $431K−22% | $469K+15% | $417K+68% | $403K+62% | $319K−26% | $400K−15% | $464K+11% | $434K+8% | $465K+46% |
| Gross profit | $535K | $559K | $470K | $470K+142% | $418K−22% | $353K−37% | $323K−31% | $245K−48% | $773K+85% | $1M+188% | $945K+193% | $814K+232% |
| R&D | $737K−8% | $691K−15% | $669K−20% | $708K−21% | $657K−11% | $569K−18% | $691K+3% | $503K−29% | $428K−35% | $527K−7% | $662K−4% | $768K+53% |
| SG&A | $3.2M+34% | $3M−56% | $3.3M−17% | $3.6M+1% | $3M−6% | $3M−2% | $3.3M+0% | $2.6M−29% | $3.7M+26% | $3.4M+14% | $3.6M+8% | $3.4M+31% |
| −$3.4M+4% | −$3.1M−60% | −$3.5M−28% | −$3.9M−10% | −$3.2M−5% | −$3.2M+1% | −$3.7M+5% | −$2.9M−26% | −$3.4M+6% | −$2.9M−10% | −$3.3M−11% | −$3.4M+17% | |
| Interest expense | $4K | $17K | $34K | $0 | $0 | $0 | n/a | n/a | n/a | n/a | $176K | $852K |
| Net income | −$3.3M+5% | −$3.1M−60% | −$3.6M−26% | −$3.8M−11% | −$3.2M−4% | −$3.1M−2% | −$3.6M+1% | −$2.8M−28% | −$3.3M+5% | −$2.8M−8% | −$3.5M−4% | −$4M+46% |
| −$409.15−48% | −$347.20−82% | −$350.70−71% | −$285.60−100% | −$127.05−69% | −$34.30−90% | $35.35 | −$12.76−96% | −$14.00−89% | −$10.15−70% | $10.85−69% | −$12.35−3% | |
| 8.1K+202747% | 9K+125% | 10.2K+253993% | 13.4K+287410% | 25.1K+208% | 89.6K+892% | 103−99% | 217K+1519% | 235.7K+841% | 279.1K+212% | 322+213% | 328K+51% |
EPS, diluted: 6 periods, Q4 FY21 to Q4 FY25: quarter's net income to common over its shares, to the cent.
Diluted shares: 5 periods, Q4 FY21 to Q4 FY25: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Healthcare nearest Tenon Medical's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| TNONTenon Medical | $1.5M | n/m | n/a | 0.3× | +80% | n/m | |
| OXBROXBRIDGE RE HOLDINGS | $7.7M | 47.5× | 9.6× | 2.8× | +40% | 4.7% | |
| EDUCEducational Development | $8.7M | 5.4× | 11.3× | 0.4× | −32% | 8.6% | |
| GTIMGood Times Restaurants | $13.6M | 6.1× | 13.6× | 0.1× | −6% | 1.7% | |
| Peer median | $8.7M | 6.1× | 11.3× | 0.4× | −6% | 4.7% |
More on Tenon Medical
Each number over time
Where it ranks
Its groups
About
- Industry
- Medical - Instruments & Supplies
- Sector
- Healthcare
Valuation data, not investment advice. Prices as of .